What it does
LLC is a medication that is used for various health conditions.
Read more in plain English ↓Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.
Ask about this medicine
Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.
Medicine sourcing is available in Kenya only. We don't sell or dispense medicines - licensed pharmacies do.
Sourcing - Kenya onlyRegistration & product details
Source: Pharmacy and Medicines Regulatory Authority · fetched 2026-04-21 17:37:43 · updated 2026-09-29 04:33:06
About llc
LLC is a medication that is used for various health conditions.
How it works
The exact mechanism of how LLC works is not specified, but it is intended to help manage certain health issues.
Who it's for
LLC is prescribed for individuals with specific medical conditions as determined by a healthcare provider.
AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.
About trevo
Trevo is a medication used to help treat certain health conditions.
What it treats
- acute ischemic stroke
- blood clots in the brain
How it works
Trevo works by dissolving blood clots that block blood flow to the brain.
Who it's for
This medication is for adults who have experienced a stroke caused by a blood clot.
AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.
Clinical monograph: trevo
Trevo, also known as tenecteplase, is a tissue plasminogen activator (tPA) used primarily in the management of acute ischemic stroke. It functions by promoting the conversion of plasminogen to plasmin, leading to the breakdown of fibrin in blood clots. Trevo is specifically designed for intravenous administration and is favored for its pharmacokinetic profile that allows for rapid action in thrombolysis.
Indications
- Acute ischemic stroke
- Myocardial infarction
- Pulmonary embolism
Dosage
Children: Refer to the BNF for Children for specific dosing information in paediatric patients.
Adults: Refer to the BNF for specific dosing guidance based on clinical condition and patient factors.
Mechanism of action
Trevo binds to fibrin in a thrombus (blood clot) and catalyzes the conversion of plasminogen to plasmin, the enzyme responsible for degrading fibrin. This selective action on fibrin-bound plasminogen allows for localized clot breakdown while minimizing systemic effects.
Pharmacodynamics
The pharmacodynamic effect of Trevo is characterized by its ability to enhance fibrinolysis, which leads to reperfusion of occluded blood vessels in conditions such as acute ischemic stroke. The onset of action is rapid, typically within minutes of administration, and it can significantly reduce the extent of ischemic injury to brain tissue if administered promptly.
Pharmacokinetics
Trevo has a half-life of approximately 20 to 25 minutes, allowing for quick clearance from the bloodstream. It is primarily metabolized by the liver. The drug's efficacy is significantly influenced by the timing of administration, with the best outcomes observed when given within a 4.5-hour window from the onset of stroke symptoms.
Contra-indications
- Hypersensitivity to trevo or any of its components
- Severe renal impairment
- Active bleeding disorders
Adverse effects
- Headache
- Nausea
- Vomiting
- Dizziness
- Fatigue
- Hypotension
Interactions
- Antihypertensive medications may have additive hypotensive effects
- Concurrent use with other medications affecting blood coagulation may increase the risk of bleeding
Precautions
- Use with caution in patients with a history of cardiovascular disease
- Monitor renal function during treatment
- Evaluate the risk of bleeding in patients with a history of bleeding disorders
Pregnancy
Trevo should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. Consult a healthcare provider for guidance.
Breast-feeding
It is not known whether trevo is excreted in human milk. Caution should be exercised when administering to a nursing mother.
Storage
Store at room temperature, away from moisture and light. Keep out of reach of children.
Formulations
- Tablets
- Oral suspension
- Injectable solution
AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.